QuiVad
My list

Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on October 21, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%
Jan 2026Apr 2026Jul 2026Oct 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 4.82% on March 10, 2025. The shaded band matches the twelve months of the first chart.

January 15, 2019 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
ActusRayPartners Limited0.90%+0.30 ptAugust 28, 2026
GSA Capital Partners LLP0.70%+0.16 ptSeptember 28, 2026
Worldquant LLC0.68%+0.10 ptOctober 21, 2026

In the United States HNSBF (OTC): 93,732 shares sold short on September 30, 2026. FINRA names no fund.

On the other side: the funds that hold Hansa Biopharma AB Titelia

Follow by RSS

Get the moves on Hansa Biopharma AB by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

441 disclosures on record for this share.
DateFund% of capitalEnd of publication
November 29, 2024Qube Research & Technologies Limited0.81%
November 18, 2024Qube Research & Technologies Limited0.70%
October 25, 2024Qube Research & Technologies Limited0.60%
October 7, 2024Qube Research & Technologies Limited0.51%
May 6, 2024Arrowstreet Capital Limited Partnership0.69%
May 3, 2024GSA Capital Partners LLP0.54%
April 5, 2024GSA Capital Partners LLP0.69%
February 29, 2024GSA Capital Partners LLP0.79%
February 5, 2024Citadel Advisors LLC0.59%
January 9, 2024Citadel Advisors LLC0.68%
January 9, 2024Worldquant LLC0.51%
January 8, 2024Citadel Advisors LLC0.71%
January 8, 2024Worldquant LLC0.60%
January 4, 2024Citadel Advisors LLC0.80%
January 3, 2024Worldquant LLC0.58%
December 27, 2023Citadel Advisors LLC0.76%
December 20, 2023GSA Capital Partners LLP0.88%
December 19, 2023Citadel Advisors LLC0.85%
December 13, 2023Citadel Advisors LLC0.70%
December 12, 2023Worldquant LLC0.69%
December 7, 2023Citadel Advisors LLC0.60%
December 4, 2023GSA Capital Partners LLP0.90%
November 29, 2023Citadel Advisors LLC0.50%
November 15, 2023GSA Capital Partners LLP0.80%
November 6, 2023PDT Partners LLC0.50%
November 3, 2023Worldquant LLC0.71%
November 1, 2023PDT Partners LLC0.50%
October 26, 2023Worldquant LLC0.60%
October 19, 2023GSA Capital Partners LLP0.71%
October 18, 2023Citadel Advisors LLC0.56%
October 13, 2023Worldquant LLC0.50%
September 26, 2023GSA Capital Partners LLP0.60%
September 25, 2023GSA Capital Partners LLP0.59%
September 21, 2023GSA Capital Partners LLP0.60%
September 8, 2023GSA Capital Partners LLP0.51%
August 25, 2023Voleon Capital Management LP0.53%
August 2, 2023Worldquant LLC0.58%
July 31, 2023Worldquant LLC0.65%
July 28, 2023Voleon Capital Management LP0.52%
July 27, 2023Worldquant LLC0.76%
July 24, 2023Voleon Capital Management LP0.50%
June 30, 2023Worldquant LLC0.80%
June 29, 2023Worldquant LLC0.79%
June 27, 2023Worldquant LLC0.80%
June 15, 2023Worldquant LLC0.70%
June 9, 2023Worldquant LLC0.60%
June 5, 2023Voleon Capital Management LP0.50%
June 1, 2023Voleon Capital Management LP0.50%
June 1, 2023Worldquant LLC0.50%
May 16, 2023Worldquant LLC0.53%

Download 441 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Hansa Biopharma AB, source Finansinspektionen, data as at October 21, 2026, https://www.quivad.com/action/hansa-biopharma-ab?page=3